Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 358Precursor Cell Lymphoblastic Leukemia-Lymphoma 164Leukemia 160Lymphoma 109Myelodysplastic Syndromes 74Lymphoma, Non-Hodgkin 66Lymphoma, Large B-Cell, Diffuse 61Lymphoma, Mantle-Cell 59Burkitt Lymphoma 58Recurrence 56Congenital Abnormalities 44Leukemia, Monocytic, Acute 39Lymphoma, Follicular 37Hodgkin Disease 35Leukemia, Myelomonocytic, Acute 34Leukemia, Erythroblastic, Acute 34Leukemia, Megakaryoblastic, Acute 32Blast Crisis 29Lymphoma, Large-Cell, Immunoblastic 27Leukemia, Myelomonocytic, Chronic 26Leukemia, Lymphocytic, Chronic, B-Cell 26Leukemia, Biphenotypic, Acute 26Leukemia, Myelogenous, Chronic, BCR-ABL Positive 24Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 19Lymphoma, B-Cell, Marginal Zone 19Anemia, Refractory, with Excess of Blasts 19Myeloproliferative Disorders 17Lymphoma, B-Cell 17Leukemia, Myeloid, Accelerated Phase 16Neoplasm, Residual 15

Interventions

Doxorubicin 8Cyclophosphamide 8Vincristine 7Prednisone 7Etoposide 6Brentuximab Vedotin 4prednylidene 3etoposide phosphate 3Bortezomib 3pembrolizumab 2deltacortene 2Vorinostat 2Prednisolone 2Ifosfamide 2tazemetostat 1romidepsin 1pirarubicin 1duvelisib 1Salvia hispanica seed extract 1Peripheral Blood Stem Cell Transplantation 1Panobinostat 1Nivolumab 1Methylprednisolone 1Methotrexate 1Melphalan 1Lenalidomide 1Lactones 1Gemcitabine 1Everolimus 1Diet, Gluten-Free 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Enteropathy-Associated T-Cell Lymphoma × Cytarabine × Clear all
NCT06692452 2026-04-01

Tazemetostat Plus CHOP in 1L T-cell Lymphoma

Dana-Farber Cancer Institute

Phase 2 Withdrawn
Lymphoid

Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, T-Cell, Peripheral, Enteropathy-Associated T-Cell Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡